Sirio Pharma Co Ltd
SZSE:300791

Watchlist Manager
Sirio Pharma Co Ltd Logo
Sirio Pharma Co Ltd
SZSE:300791
Watchlist
Price: 26.96 CNY -3.54%
Market Cap: 6.4B CNY
Have any thoughts about
Sirio Pharma Co Ltd?
Write Note

Sirio Pharma Co Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sirio Pharma Co Ltd
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Sirio Pharma Co Ltd
SZSE:300791
Cash from Financing Activities
-ÂĄ91.1m
CAGR 3-Years
1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Cash from Financing Activities
-ÂĄ5.9B
CAGR 3-Years
13%
CAGR 5-Years
N/A
CAGR 10-Years
-32%
S
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
Cash from Financing Activities
-ÂĄ590.7m
CAGR 3-Years
-10%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Cash from Financing Activities
-ÂĄ846.7m
CAGR 3-Years
-49%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Cash from Financing Activities
-ÂĄ372.2m
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Cash from Financing Activities
ÂĄ51.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sirio Pharma Co Ltd
Glance View

Market Cap
6.4B CNY
Industry
Consumer products

Sirio Pharma Co. Ltd. manufactures dietary supplement products. The company is headquartered in Shantou, Guangdong and currently employs 2,456 full-time employees. The company went IPO on 2019-09-25. The firm's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The firm's own brand is WEWOW nutritional health food. The firm distributes its products both in the domestic market and to overseas markets.

Intrinsic Value
35.1 CNY
Undervaluation 23%
Intrinsic Value
Price

See Also

What is Sirio Pharma Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-91.1m CNY

Based on the financial report for Dec 31, 2023, Sirio Pharma Co Ltd's Cash from Financing Activities amounts to -91.1m CNY.

What is Sirio Pharma Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
1%

Over the last year, the Cash from Financing Activities growth was -17%. The average annual Cash from Financing Activities growth rates for Sirio Pharma Co Ltd have been 1% over the past three years .

Back to Top